abemaciclib,ruxolitinib
eli lilly,novartis,incyte
['mpnsm', 'rux,(-crux),(-trux),(-deruxtecan)', 'abemaciclib', '#mpn', 'ruxolitinib', 'abema', 'rux,(-crux),(-trux)']
congress| #asco23 jan bewersdorf discusses the poor prognosis of ruxolitinib (median os: 13 months) in patients with mf who discontinue treatment due to aes or lack of response. a new study will evaluate mtd of ruxolitinib + abemaciclib in patients with mf #mpnsm 
Lifting levels of knowledge in myeloproliferative neoplasms (MPN). A global online platform providing latest treatment options and medical information #mpnsm